drugset / Trial / NCT00864435
A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
To compare the rate and extent of absorption of carvedilol from a test formulation of Carvedilol 12.5 mg Tablets versus the reference Coreg® 12.5 mg Tablets under fasting conditions.
Timeline
- Start
- 2005-10
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 12.5 mg | — |
Indications
No indication recorded.